Wanting Hao

Dr. Wanting Hao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2019 in Molecules
Verified
Journal Article
Open access
PDF file
WHWanting Hao
Wanting Hao
YZYuchan Zhang
Yuchan Zhang
JFJingchuan Fan
Jingchuan Fan
HLHandeng Liu
Handeng Liu
QSQi Shi
Qi Shi
GZGuangchao Zang
Guangchao Zang
Copper nanowires (Cu NWs) were modified with graphene oxide (GO) nanosheets to obtain a sensor for simultaneous voltammetric determination of ascorbic acid (AA), dopamine (DA) and acetaminophen (AC). The nanocomposite was obtained via sonication, and its structures were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD) and energy-dispersive X-ray spectroscopy (EDS). The electrochemical oxidation activity of the materials (placed on a glassy carbon electrode) was studied by cyclic voltammetry and differential pulse voltammetry. Due to the synergistic effect of Cu NWs and GO, the specific surface, electrochemical oxidation performance and conductivity are improved when compared to each individual component. The peaks for AA (−0.08 V), DA (+0.16 V), and AC (+0.38 V) are well separated. The sensor has wide linear ranges which are from 1–60 μM, 1–100 μM, and 1–100 μM for AA, DA, and AC, respectively, when operated in the differential pulse voltammetric mode. The detection limits are 50, 410 and 40 nM, respectively. Potential interferences by uric acid (20 μM), glucose (10 mM), NaCl (1 mM), and KCl (1 mM) were tested for AA (1 μΜ), DA (1 μΜ), and AC (1 μΜ) and were found to be insignificant. The method was successfully applied to the quantification of AA, DA, and AC in spiked serum samples.

1 February 2022 in Clinical Nuclear Medicine
Verified
Journal Article
Open access
WHWanting Hao
Wanting Hao
YLYa-ming Li
Ya-ming Li
BDBulin Du
Bulin Du
XLXuena Li
Xuena Li
An 84-year-old man presented with dysphagia for 20 days. The biopsies of the multiple lesions through gastroscopy revealed gastric diffuse large B-cell lymphoma and gastric adenocarcinoma. Staging 18F-FDG PET/CT showed multiple hypermetabolic lesions in the stomach, abdomen, and pelvis. After 4 courses of chemotherapy, except for the lesion of biopsy-proven gastric adenocarcinoma, other hypermetabolic lesions in stomach and other sites returned to normal on posttherapy 18F-FDG PET/CT. This case indicated that 18F-FDG PET/CT can track differential treatment response of synchronous gastric tumors and guide subsequent therapy.